Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
J Headache Pain. 2023 Apr 21;24(1):44. doi: 10.1186/s10194-023-01580-7.
Central sensitization has been widely accepted as an underlying pathophysiological mechanism of chronic migraine (CM), activation of cannabinoid type-1 receptor (CB1R) exerts antinociceptive effects by relieving central sensitization in many pain models. However, the role of CB1R in the central sensitization of CM is still unclear.
A CM model was established by infusing inflammatory soup (IS) into the dura of male Wistar rats for 7 days, and hyperalgesia was assessed by the mechanical and thermal thresholds. In the periaqueductal gray (PAG), the mRNA and protein levels of CB1R and hyperpolarization-activated cyclic nucleotide-gated cation channel 2 (HCN2) were measured by qRT-PCR and western blotting. After intraventricular injection of Noladin ether (NE) (a CB1R agonist), ZD 7288 (an HCN2 blocker), and AM 251 (a CB1R antagonist), the expression of tyrosine phosphorylation of N-methyl-D-aspartate receptor subtype 2B (pNR2B), calcium-calmodulin-dependent kinase II (CaMKII), and phosphorylated cAMP-responsive element binding protein (pCREB) was detected, and central sensitization was evaluated by the expression of calcitonin gene-related peptide (CGRP), c-Fos, and substance P (SP). Synaptic-associated protein (postsynaptic density protein 95 (PSD95) and synaptophysin (Syp)) and synaptic ultrastructure were detected to explore synaptic plasticity in central sensitization.
We observed that the mRNA and protein levels of CB1R and HCN2 were both significantly increased in the PAG of CM rats. The application of NE or ZD 7288 ameliorated IS-induced hyperalgesia; repressed the pNR2B/CaMKII/pCREB pathway; reduced CGRP, c-Fos, SP, PSD95, and Syp expression; and inhibited synaptic transmission. Strikingly, the application of ZD 7288 relieved AM 251-evoked elevation of pNR2B, CGRP, and c-Fos expression.
These data reveal that activation of CB1R alleviates central sensitization by regulating HCN2-pNR2B signaling in CM rats. The activation of CB1R might have a positive influence on the prevention of CM by mitigating central sensitization.
中枢敏化已被广泛接受为慢性偏头痛(CM)的潜在病理生理机制,大麻素 1 型受体(CB1R)的激活通过缓解许多疼痛模型中的中枢敏化发挥镇痛作用。然而,CB1R 在 CM 的中枢敏化中的作用仍不清楚。
通过在雄性 Wistar 大鼠的硬脑膜中输注炎症汤(IS)7 天来建立 CM 模型,并通过机械和热阈值评估痛觉过敏。在导水管周围灰质(PAG)中,通过 qRT-PCR 和 Western blot 测量 CB1R 和超极化激活环核苷酸门控阳离子通道 2(HCN2)的 mRNA 和蛋白水平。脑室注射 Noladin 醚(NE)(CB1R 激动剂)、ZD 7288(HCN2 阻断剂)和 AM 251(CB1R 拮抗剂)后,检测 N-甲基-D-天冬氨酸受体 2B 亚基(pNR2B)、钙调蛋白依赖性激酶 II(CaMKII)和磷酸化 cAMP 反应元件结合蛋白(pCREB)的酪氨酸磷酸化表达,并通过降钙素基因相关肽(CGRP)、c-Fos 和 P 物质(SP)的表达评估中枢敏化。检测突触相关蛋白(突触后密度蛋白 95(PSD95)和突触小体蛋白(Syp))和突触超微结构,以探索中枢敏化中的突触可塑性。
我们观察到 CB1R 和 HCN2 的 mRNA 和蛋白水平在 CM 大鼠的 PAG 中均显著增加。NE 或 ZD 7288 的应用改善了 IS 诱导的痛觉过敏;抑制 pNR2B/CaMKII/pCREB 通路;降低 CGRP、c-Fos、SP、PSD95 和 Syp 的表达;并抑制突触传递。值得注意的是,ZD 7288 缓解了 AM 251 诱发的 pNR2B、CGRP 和 c-Fos 表达升高。
这些数据表明,CB1R 的激活通过调节 CM 大鼠中的 HCN2-pNR2B 信号来减轻中枢敏化。CB1R 的激活可能通过减轻中枢敏化对 CM 的预防产生积极影响。